| Net Cash Provided by (Used in) Operating Activities |
$3,470,000 |
USD |
-20% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$12,014,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
45,585,728 |
shares |
168% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$3,475,000 |
USD |
-154% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$102,969,000 |
USD |
2.9% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$104,821,000 |
USD |
2.8% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$90,142,000 |
USD |
1.5% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$3,031,000 |
USD |
6.9% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$486,879,000 |
USD |
4.7% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Share-based Payment Arrangement, Expense |
$744,000 |
USD |
-30% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$15,000 |
USD |
-98% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |